home / stock / nhwk / nhwk articles


NHWK Articles, NightHawk Biosciences Inc.

Stock Information

Company Name: NightHawk Biosciences Inc.
Stock Symbol: NHWK
Market: NYSE

Menu

NHWK NHWK Quote NHWK Short NHWK News NHWK Articles NHWK Message Board
Get NHWK Alerts

News, Short Squeeze, Breakout and More Instantly...

Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major University | Benzinga

DURHAM, N.C., March 19, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufactur...

Scorpius Holdings, Inc. Announces Pricing of Public Offering | Benzinga

DURHAM, N.C., March 08, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE:SCPX), ("Scorpius" or the "Company"), an integrated contract deve...

NightHawk's Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating Officer | Benzinga

DURHAM, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE:NHWK) ("NightHawk" or the "Company"), an integrated contract develop...

NightHawk's Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New Client | Benzinga

DURHAM, N.C., Jan. 16, 2024 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE:NHWK) ("NightHawk" or the "Company"), an integrated contract develop...

Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline...

NightHawk Biosciences Announces Strategic Shift into a Pure-Play Large Molecule Biomanufacturing CDMO to Capitalize on Rapid Growth in Sales Pipeline along with Divestiture of Non-Core Assets | Benzinga

Over $20 million in signed manufacturing contracts which includepremier biotech/pharma companies and research institutes Elusys divestiture and R&...

Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withd...

Next 10